2018 Report on ER/LA Opioid REMS CME Activities in PARS

This report shows the scope of continuing education (CE) activities offered by accredited providers within the ACCME Accreditation System in support of the US Food and Drug Administration (FDA) Risk Evaluation and Mitigation Strategies (REMS) for Extended-Release and Long-Acting (ER/LA) Opioid Analgesics. 

Click the link below to download the 2018 report.